CEO Sabrina Martucci Johnson announced the company's intent to make its proprietary Sildenafil Cream formulation available by prescription through a 503B-registered outsourcing facility in Q4 2025.

We are proud to announce that we are taking action to make our proprietary Sildenafil Cream formulation available via prescription this year as a compounded drug under Section 503B of the FDCA ...

Studies of selective phosphodiesterase type 5 inhibitors (sildenafil [Viagra], vardenafil [Levitra], and tadalafil [Cialis]) as therapy for women with sexual arousal disorder have produced mixed ...